Skip to main content
DNA Labs India

Comprehensive Hereditary Cancer Panel - 157 Genes Test

DNA Labs India | ISO 9001:2015 Certified

Comprehensive Hereditary Cancer Panel - 157 Genes Test

Short Name: Hereditary Cancer Panel 157 Genes

Also known as: Multi-gene Cancer Panel, Hereditary Cancer Genetic Test, Cancer Predisposition Panel

Comprehensive Hereditary Cancer Panel - 157 Genes Test test available at DNA Labs India for ₹30,000. Uses Next Generation Sequencing (NGS) on Blood samples. Results in Results are typically available within 15-20 business days after sample receipt.. Free home collection in 300+ cities across India.

Next Generation Sequencing (NGS) Panel TestAdults with cancer risk indications🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify genetic variants that increase the risk of hereditary cancers, enabling early detection, personalized prevention strategies, and informed clinical management for individuals and families.

Test Code
3436
Price
₹30,000
Sample Type
Blood
Result Time
Results are typically available within 15-20 business days after sample receipt.
Fasting Required
No
Method
Next Generation Sequencing (NGS)
Step 1

Sample Collection

No specific preparation required. Ensure informed consent is obtained and genetic counseling is recommended prior to testing.

Method: Venipuncture

Step 2

Laboratory Analysis

A blood sample is drawn via venipuncture from a vein in the arm by a trained phlebotomist.

Step 3

Report Delivery

Apply pressure to the puncture site to prevent bleeding. Resume normal activities unless otherwise advised.

Timeline: Results are typically available within 15-20 business days after sample receipt.

Patient Instructions

1
Before the Test:Genetic counseling is recommended to discuss implications, benefits, and limitations of testing.
2
During the Test:The test involves a simple blood draw; no special procedures are required during the analysis phase.
3
After the Test:Results are delivered via online portal, email, or WhatsApp. Follow-up with a healthcare provider is advised for interpretation.

About This Test

Who Should Get This Test

The purpose of this test is to identify genetic variants that increase the risk of hereditary cancers, enabling early detection, personalized prevention strategies, and informed clinical management for individuals and families.

How to Prepare

  • Verify patient identity and consent
  • Use sterile equipment and aseptic technique
  • Collect 5-10 mL blood in an EDTA tube
  • Label the sample correctly with patient details
  • Transport the sample to the lab at room temperature within 48 hours

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"This comprehensive panel is crucial for identifying individuals at high risk of hereditary cancers, enabling personalized prevention strategies and informed clinical decisions."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood
Sample Volume5-10 mL
ContainerEDTA Tube
Collection MethodVenipuncture

Sample Stability

Blood sample stable for 48 hours at room temperature
For longer storage, refrigerate at 2-8°C for up to 7 days
Sample Rejection Criteria:
  • Hemolyzed or clotted samples
  • Insufficient sample volume
  • Incorrect sample type or container
  • Missing patient identification or consent

Understanding Your Results

Results are interpreted based on the detection of genetic variants. Pathogenic or likely pathogenic variants indicate increased cancer risk, requiring clinical management changes. Variants of uncertain significance (VUS) need ongoing monitoring. Negative results may still warrant family history-based screening.
📊

Pathogenic/Likely Pathogenic Variant Detected

High risk for hereditary cancer; recommend genetic counseling, enhanced screening, and possible preventive measures.

📊

Variant of Uncertain Significance (VUS)

Clinical significance unknown; monitor for reclassification and consider family studies.

📊

Negative Result

No pathogenic variants detected in tested genes; cancer risk based on family history may still apply.

⚠️ When to Consult a Doctor:

Consult a healthcare provider or genetic counselor immediately if pathogenic variants are detected, or for guidance on VUS or negative results with strong family history.

Limitations

  • May not detect all genetic variants, including deep intronic mutations
  • Variants of uncertain significance (VUS) may require ongoing monitoring and reclassification
  • Negative results do not eliminate cancer risk based on family history or other factors

Risks & Considerations

  • Minimal risk from blood draw, such as bruising or infection
  • Psychological impact from results, requiring genetic counseling support

Interfering Factors

  • Sample contamination
  • Insufficient DNA quality or quantity
  • Hemolyzed or degraded samples

Compare With Similar Tests

TestComprehensive Hereditary Cancer Panel - 157 Genes TestBRCA1/2 Gene TestLynch Syndrome PanelSingle-Gene TestingTumor Profiling
ComparisonComprehensive Hereditary Cancer Panel - 157 Genes Test

Frequently Asked Questions

What is the Comprehensive Hereditary Cancer Panel?
It is a genetic test that analyzes 157 genes associated with hereditary cancer predisposition syndromes using Next Generation Sequencing (NGS) technology.
Who should consider this test?
Individuals with a personal or family history of cancer, early onset of cancer, multiple primary cancers, or specific tumor characteristics.
What is the cost of the test?
The test costs INR 30000.0, which includes sample collection, analysis, and report generation.
How is the sample collected?
A blood sample is collected via venipuncture at home or a walk-in center by a trained professional.
Is fasting required before the test?
No, fasting is not required for this genetic test.
What is the turnaround time for results?
Results are typically available within 15-20 business days after sample receipt.
What do the results mean?
Results indicate the presence or absence of pathogenic variants. Pathogenic variants increase cancer risk, while VUS require monitoring, and negative results may still warrant screening.
Is the test covered by insurance?
Coverage varies; it is not typically covered under government schemes like PMJAY, but private insurance may cover it depending on the policy.
What are the limitations of the test?
The test may not detect all genetic variants, and VUS may require reclassification. Negative results do not eliminate cancer risk.
How accurate is the test?
The test uses advanced NGS technology with high detection rates, but accuracy depends on sample quality and variant classification.
Can I get home collection for this test?
Yes, home collection is available across India, and outstation samples are accepted.
What should I do after receiving the results?
Consult a healthcare provider or genetic counselor for interpretation and personalized management plans.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.